Home > Healthcare & Medical Devices > Cell Therapy Technologies Market
Cell Therapy Technologies Market size was valued at around USD 4 billion in 2022 and is projected to expand at a CAGR of 10-15% by 2032.
Cell therapy involves the injection of active cells into a patient’s body to treat certain conditions. This treatment cures various diseases by modifying certain development factors. In this procedure, cells from the patient or a donor are altered outside the body and then reintroduced into the patient.
Cell therapy technologies are used in clinical research for HIV/AIDS, cancer, and various contagious diseases, as well as for diagnostic & prognostic information. Factors including population growth, climate change, and increased human-animal interaction have surged the risk of new viral outbreaks. This has expanded the adoption of cell therapy treatments, driving cell therapy technologies market outlook.
By cell type, the T-cell segment market is expected to grow significantly over the forecast period owing to the increasing research & improvements in cell-based immunotherapies including CAR-T therapy and the rising need for better therapeutic approaches for diseases such as cancer and Cardiovascular Diseases (CVDs). Kymriah is the only CAR-T cell treatment approved for adult & pediatric patients. It was reported to be successful in treating high-risk patients including those who had been extensively treated or have developed drug resistance.
Based on end user, the cell bank & research institutes segment accounted for the largest market share. Several recent collaborative research & innovation initiatives have been launched as part of the EU's research & innovation financing program, Horizon 2020. The program involves gene therapy trials with viral vectors. As a result, gene transfer technology is gaining popularity around the globe.
The cell therapy technologies market in North America is set to witness high demand due to advancements in research facilities and cell therapy research investigations. Other factors driving market growth are the region’s expanding number of research laboratories and increasing partnerships among the key players to develop novel cell therapy treatments.
The prominent players in the cell therapy technologies market are Thermo Fisher Scientific, Inc., Merck KGaA, Danaher Corporation, Sartorius AG, FUJIFILM Irvine Scientific, Inc., Lonza Group AG, Becton Dickinson and Company, GE Healthcare, Terumo BCT, Avantor, Inc., Bio-Techne Corporation, and Corning Incorporated.